Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Elkady A, Aboulfotuh S, Ali EM, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Iijima S, Tanaka Y.

World J Gastroenterol. 2013 Oct 7;19(37):6214-20. doi: 10.3748/wjg.v19.i37.6214.

2.
3.

Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.

Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.

Biol Blood Marrow Transplant. 2010 Jun;16(6):809-17. doi: 10.1016/j.bbmt.2009.12.533. Epub 2010 Jan 7.

4.

Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.

Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, Ueda R, Mizokami M.

J Med Virol. 2011 Mar;83(3):412-8. doi: 10.1002/jmv.21995.

PMID:
21264861
5.

Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study.

Wang Y, Luo XM, Yang D, Zhang J, Zhuo HY, Zhang J, Jiang Y.

World J Gastroenterol. 2013 Feb 14;19(6):923-30. doi: 10.3748/wjg.v19.i6.923.

6.

Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma.

Matsui T, Kang JH, Nojima M, Tomonari A, Aoki H, Yamazaki H, Yane K, Tsuji K, Andoh S, Andoh S, Sakai H, Maemori M, Maguchi H, Tanaka Y.

J Med Virol. 2013 Nov;85(11):1900-6. doi: 10.1002/jmv.23694. Epub 2013 Aug 7.

PMID:
23926082
7.

Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.

Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.

J Viral Hepat. 2006 Sep;13(9):591-6.

PMID:
16907845
8.

Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.

Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A, Ohmura H, Ikuta Y, Idobe Y, Kawasaki H.

Eur J Haematol. 2001 Jul;67(1):45-50.

PMID:
11553266
9.

Prospective study of hepatitis B virus reactivation in patients with hematological malignancies.

Pompili M, Basso M, Hohaus S, Bosco G, Nosotti L, D'Andrea M, Fenu S, Grieco A, Laurenti L, Mirisola C, Pagano L, Rapaccini GL, Sica S, Storti S, Landolfi R.

Ann Hepatol. 2015 Mar-Apr;14(2):168-74.

10.

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.

Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa AM, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, GĂ©rolami R.

J Viral Hepat. 2010 Nov;17(11):807-15. doi: 10.1111/j.1365-2893.2009.01239.x.

PMID:
20002298
11.

Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.

Liao YP, Jiang JL, Zou WY, Xu DR, Li J.

World J Gastroenterol. 2015 Apr 14;21(14):4284-92. doi: 10.3748/wjg.v21.i14.4284.

12.

Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.

Kim E, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Hepatogastroenterology. 2014 Sep;61(134):1704-11.

PMID:
25436366
13.

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.

Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

PMID:
21719446
14.

Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.

El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, Chiba T, Hosney AM.

J Gastroenterol. 2009;44(4):359-64. doi: 10.1007/s00535-009-0020-3. Epub 2009 Mar 7.

PMID:
19271112
15.

Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.

Feeney SA, McCaughey C, Watt AP, Agnaf MR, McDougall N, Wend UC, Gerlich WH, Coyle PV.

J Med Virol. 2013 Apr;85(4):597-601. doi: 10.1002/jmv.23513. Epub 2013 Jan 28.

PMID:
23359331
16.

Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.

Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.

J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942.

PMID:
19247200
17.

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy.

Manzano-Alonso ML, Castellano-Tortajada G.

World J Gastroenterol. 2011 Mar 28;17(12):1531-7. doi: 10.3748/wjg.v17.i12. 1531. Review.

18.

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.

Tan J, Zhou J, Zhao P, Wei J.

Clin Rheumatol. 2012 Aug;31(8):1169-75. doi: 10.1007/s10067-012-1988-2. Epub 2012 Apr 28.

PMID:
22544263
19.

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.

Viganò M, Vener C, Lampertico P, Annaloro C, Pichoud C, Zoulim F, Facchetti F, Poli F, Scalamogna M, Deliliers GL, Colombo M.

Bone Marrow Transplant. 2011 Jan;46(1):125-31. doi: 10.1038/bmt.2010.70. Epub 2010 Apr 12.

PMID:
20383209
20.

Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

Seto WK, Chan TS, Hwang YY, Wong DK, Fung J, Liu KS, Gill H, Lam YF, Lie AK, Lai CL, Kwong YL, Yuen MF.

J Clin Oncol. 2014 Nov 20;32(33):3736-43. doi: 10.1200/JCO.2014.56.7081. Epub 2014 Oct 6.

Items per page

Supplemental Content

Write to the Help Desk